Advertiser Disclosure

advertising disclaimer
Skip to main content
pharmacy

Amazon Launches Online Pharmacy Service: How Will It Impact Real Estate Investors?


Nov 17, 2020 by Maurie Backman
Get our 43-Page Guide to Real Estate Investing Today!

Real estate has long been the go-to investment for those looking to build long-term wealth for generations. Let us help you navigate this asset class by signing up for our comprehensive real estate investing guide.

*By submitting your email you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.

These days, there are very few things Amazon (NASDAQ: AMZN) doesn't seem to have its hands in. The online retail giant recently opened its first self-named grocery store, Amazon Fresh, and while its latest venture is online-based, it's definitely something with the potential to shake up the world of commercial real estate.

Introducing Amazon Pharmacy

Amazon is barging into the healthcare industry with its newly launched Amazon Pharmacy. Amazon customers can sign up for the service and use it to order commonly prescribed medications, like insulin or other drugs used to treat chronic conditions. However, Amazon Pharmacy will not offer Schedule II medications like opioids through its online pharmacy.

Amazon Prime members will get a number of perks should they choose to use the new pharmacy service. These include free two-day shipping as well as discounts on medication. In fact, Amazon claims that those who use its pharmacy service will be able to save up to 80% on generic medications and 40% on brand-name medication when paying without insurance. The pharmacy program will be in place in 45 states this week, and Amazon expects to expand soon.

A mixed bag for real estate investors

Amazon's entry into the pharmacy space doesn't come as a shock. For consumers, the convenience of prescription delivery makes it an extremely valuable offering. But on the real estate investing end, there may be some concern that Amazon's arrival into the world of pharmacy products will hurt brick-and-mortar stores.

If customers can get their prescription refills through Amazon, they won't need to visit their local pharmacies in person, which means those stores will lose the revenue that comes with added purchases -- things like over-the-counter medication, beauty products, snacks, and other pharmacy staples. A substantial loss of revenue could cause pharmacies to close up shop, resulting in shopping center vacancies.

Of course, the one thing Amazon Pharmacy can't replace in the pharmacy experience: the concept of getting to talk to a pharmacy technician in person and ask questions when picking up a prescription. But between the savings and convenience, there's a good chance Amazon's new pharmacy offering will really take off, which could be bad news for physical stores. Plus, Amazon claims that those who use its pharmacy service will have the option to speak to an actual pharmacist for advice.

That said, as part of Amazon's new pharmacy program, Prime members will have the option to save on medication bought in person at over 50,000 pharmacy locations across the country, including Walgreens (NASDAQ: WBA), Rite Aid (NYSE: RAD), and CVS (NYSE: CVS). Those savings could prompt consumers to continue to visit pharmacy chain locations, despite the option to order prescription drugs online.

The Millionacres bottom line

It's too soon to predict how Amazon's latest offering will impact the pharmacy business. If pharmacy chains are able to partner well with Amazon, it could create a situation where everyone truly wins out, giving real estate investors much less to worry about.

But if Amazon's pharmacy service starts to negate the need for stores, it could result in nationwide vacancies that hurt shopping center REITs (real estate investment trusts) -- and the people who invest their money in them.

Unfair Advantages: How Real Estate Became a Billionaire Factory

You probably know that real estate has long been the playground for the rich and well connected, and that according to recently published data it’s also been the best performing investment in modern history. And with a set of unfair advantages that are completely unheard of with other investments, it’s no surprise why.

But those barriers have come crashing down - and now it’s possible to build REAL wealth through real estate at a fraction of what it used to cost, meaning the unfair advantages are now available to individuals like you.

To get started, we’ve assembled a comprehensive guide that outlines everything you need to know about investing in real estate - and have made it available for FREE today. Simply click here to learn more and access your complimentary copy.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Maurie Backman owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon. The Motley Fool recommends CVS Health and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.